Counts of positive, neutral, and negative news items. Not a price chart.
Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
Showing 3 stories from May 2026
Show allThe items moving the net sentiment the most, by direction and influence.
Drug Deregulation Reversal Threatens Pharma Stocks: PPMA Warns of Shortages
Drug pricing (DRAP) · Medium influence · Long term
SBP Foreign Exchange Reserves Rise to $17.15 Billion: Positive for Import-Dependent Stocks
FX reserves / import cover · Low influence · Short term
Pakistan's FX Reserves Rise $1.2 Billion on IMF, Panda Bond Inflows: Positive for Import-Reliant Stocks
FX reserves / import cover · Low influence · Short term
No direct news naming ABOT in this range yet.
Macro, commodity, FX and regulatory forces that moved ABOT in this range, with the stories behind each.
Sign up free to track ABOT, unlock full history and the complete driver breakdown, and get alerts when sentiment shifts.
Track ABOT for freeInformational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
Also monitored for ABOT (no news in this range): PKR/USD exchange rate, Import restrictions / LC curbs, Consumer demand & purchasing power.
How news sentiment on Abbott Laboratories Pakistan (ABOT) has built up over time. Each bar sums the direction of every story TradeTidings published in the period, weighted by how influential we rated it, not just a plain count, so a single high-influence negative story can outweigh several small positive ones. Hover a bar for its exact figures, or click one to filter the stories below to that period. Our own original analysis, not a copied index or a price chart, and not a prediction.
